Literature DB >> 31594404

Structure and development of single domain antibodies as modules for therapeutics and diagnostics.

Robert J Hoey1, Hyeyoung Eom1, James R Horn1.   

Abstract

Keywords:  Camelid single domain antibodies; VHH; antibody engineering; antibody structure; nanobody; therapeutic antibody

Year:  2019        PMID： 31594404      PMCID： PMC6920669          DOI： 10.1177/1535370219881129

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  78 in total

1.  Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography.

Authors:  Elliott J Franco; Gregory J Sonneson; Thomas J DeLegge; Heike Hofstetter; James R Horn; Oliver Hofstetter
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-06-13       Impact factor: 3.205

2.  A combinatorial approach to engineering a dual-specific metal switch antibody.

Authors:  Sean W Fanning; Megan L Murtaugh; James R Horn
Journal:  Biochemistry       Date:  2011-05-18       Impact factor: 3.162

Review 3.  Trends in therapeutic antibody affinity maturation: From in-vitro towards next-generation sequencing approaches.

Authors:  Maryam Tabasinezhad; Yeganeh Talebkhan; Wolfgang Wenzel; Hamzeh Rahimi; Eskandar Omidinia; Fereidoun Mahboudi
Journal:  Immunol Lett       Date:  2019-06-24       Impact factor: 3.685

Review 4.  Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.

Authors:  Søren B van Witteloostuijn; Søren L Pedersen; Knud J Jensen
Journal:  ChemMedChem       Date:  2016-10-24       Impact factor: 3.466

5.  Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae.

Authors:  K E Conrath; M Lauwereys; M Galleni; A Matagne; J M Frère; J Kinne; L Wyns; S Muyldermans
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.

Authors:  Erwin De Genst; Karen Silence; Klaas Decanniere; Katja Conrath; Remy Loris; Jörg Kinne; Serge Muyldermans; Lode Wyns
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

7.  Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor.

Authors:  Tao Che; Susruta Majumdar; Saheem A Zaidi; Pauline Ondachi; John D McCorvy; Sheng Wang; Philip D Mosier; Rajendra Uprety; Eyal Vardy; Brian E Krumm; Gye Won Han; Ming-Yue Lee; Els Pardon; Jan Steyaert; Xi-Ping Huang; Ryan T Strachan; Alexandra R Tribo; Gavril W Pasternak; F Ivy Carroll; Raymond C Stevens; Vadim Cherezov; Vsevolod Katritch; Daniel Wacker; Bryan L Roth
Journal:  Cell       Date:  2018-01-04       Impact factor: 41.582

8.  NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Authors:  Sandrine Moutel; Nicolas Bery; Virginie Bernard; Laura Keller; Emilie Lemesre; Ario de Marco; Laetitia Ligat; Jean-Christophe Rain; Gilles Favre; Aurélien Olichon; Franck Perez
Journal:  Elife       Date:  2016-07-19       Impact factor: 8.140

Review 9.  Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview.

Authors:  Ellen R Goldman; Jinny L Liu; Dan Zabetakis; George P Anderson
Journal:  Front Immunol       Date:  2017-07-25       Impact factor: 7.561

10.  Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease.

Authors:  J Scott Crowe; Kevin J Roberts; Timothy M Carlton; Luana Maggiore; Marion F Cubitt; Simon Clare; Katherine Harcourt; Jill Reckless; Thomas T MacDonald; Keith P Ray; Anna Vossenkämper; Michael R West
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379
View more
  10 in total

Review 1.  Applications of Bacillus subtilis Spores in Biotechnology and Advanced Materials.

Authors:  Xiaopei Zhang; Amal Al-Dossary; Myer Hussain; Peter Setlow; Jiahe Li
Journal:  Appl Environ Microbiol       Date:  2020-08-18       Impact factor: 4.792

2.  Structural biology: Gaining atomic level insight into the biological function of macromolecules.

Authors:  Thomas B Thompson; Rhett A Kovall
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-13

Review 3.  Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies.

Authors:  Lanying Du; Yang Yang; Xiujuan Zhang; Fang Li
Journal:  Nanoscale       Date:  2022-01-27       Impact factor: 7.790

4.  Nanobody Paratope Ensembles in Solution Characterized by MD Simulations and NMR.

Authors:  Monica L Fernández-Quintero; Eugene F DeRose; Scott A Gabel; Geoffrey A Mueller; Klaus R Liedl
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

5.  Selection and Modelling of a New Single-Domain Intrabody Against TDP-43.

Authors:  Martina Gilodi; Simonetta Lisi; Erika F Dudás; Marco Fantini; Rita Puglisi; Alexandra Louka; Paolo Marcatili; Antonino Cattaneo; Annalisa Pastore
Journal:  Front Mol Biosci       Date:  2022-02-14

6.  Development of a horseradish peroxidase-nanobody fusion protein for visual detection of ochratoxin A by dot immunoassay.

Authors:  Qi Chen; Yuanyuan Wang; Fujing Mao; Benchao Su; Kunlu Bao; Zeling Zhang; Guifang Xie; Xing Liu
Journal:  RSC Adv       Date:  2020-09-11       Impact factor: 4.036

7.  Comparison of the oxidative respiratory burst and mitogen-induced leukocyte responses of camels, goats, sheep, and cows.

Authors:  Abeer Al-Hamrashdi; Khalid Al-Habsi; Elshafie I Elshafie; Eugene H Johnson
Journal:  Vet World       Date:  2022-06-07

8.  The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.

Authors:  Monica L Fernández-Quintero; Anna-Lena M Fischer; Janik Kokot; Franz Waibl; Clarissa A Seidler; Klaus R Liedl
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

9.  The reduced form of the antibody CH2 domain.

Authors:  Zhaoyong Xi; Xianglei Liu; Rui Lin; John D Persons; Tatiana V Ilina; Wei Li; Dimiter S Dimitrov; Rieko Ishima
Journal:  Protein Sci       Date:  2021-06-16       Impact factor: 6.993

10.  Autoimmune diseases - New insights into a troublesome field.

Authors:  Thomas Lung; Benjamin Sakem; Andreas Hemmerle; Michèle Nydegger; Martin Risch; Lorenz Risch; Urs Nydegger
Journal:  J Transl Autoimmun       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.